Neuren has filed yet another Compositions of Trofinetide US patent application, with the latest application filed last November and only published last week.
The first Compositions of Trofinetide US patent application was filed in June 2021 and granted in June 2022, the second, recently referred to by Sillazze, was filed in June 2022 and granted in January this year.
United States of America
Application Number 18516604
Application Date 21.11.2023
Publication Number 20240109841
Publication Date 04.04.2024
Publication Kind A1
United States of America
Application Number 17847736
Application Date 23.06.2022
Publication Number 20220324799
Publication Date 13.10.2022
Grant Number 11866406
Grant Date 09.01.2024
Publication Kind B2
United States of America
Application Number 17347135
Application Date 14.06.2021
Publication Number 20220055987
Publication Date 24.02.2022
Grant Number 11370755
Grant Date 28.06.2022
Publication Kind B2
Ann: Comment on research report, page-316
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.71 |
Change
0.000(0.00%) |
Mkt cap ! $2.644B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350 | $30.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.68 | 45 | 1 |
View Market Depth
| Last trade - 16.16pm 24/05/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable